The Irish Times

Hedge funds circle Woodford’s investment trust

Patient Capital Trust is most bet-against investment trust in FTSE 350

Mon Jun 10 2019 - 20:03

Theravance Biopharma Ireland agrees potential $1bn deal

The company, whose parent is listed on the Nasdaq, to do study on Crohn’s disease

Thu Feb 08 2018 - 11:44

Soundings from China boost global markets

European shares head for longest winning streak since Chinese devaluation

Wed Sept 09 2015 - 21:47

Elan loses shareholder support but Royalty bid may also perish

Outcome of special meeting in Dublin leaves sides effectively in stalemate

Mon Jun 17 2013 - 19:57

Stalemate for Royalty Pharma’s bid for Elan as shareholders approve buyback programme

US pharma firm invited to bring forward “a new offer” following egm

Mon Jun 17 2013 - 11:46

Royalty Pharma co-founder writes open letter to board of Elan ahead of egm

Elan shareholders will today vote on a series of acquisitions

Mon Jun 17 2013 - 08:01

Elan shareholders mull the unravelling of a business

How the Irish biotech firm got to this point and how the EGM may play out

Sun Jun 16 2013 - 16:02

Royalty gets injunction in challenge to Takeover Panel on Elan bid

Court move means bid will not lapse pending full hearing even if shareholders back certain resolutions

Thu Jun 13 2013 - 18:05

Much noise, little clarity as Royalty and Elan go to war

Cantillon: Shareholders at Elan must be nonplussed by the frantic claim and counterclaim

Thu Jun 13 2013 - 01:00

Failure of Royalty Pharma bid likely to hit Elan share price, say analysts

Fate of $6.7bn offer will be decided by shareholders at extraordinary general meeting on Monday

Thu Jun 13 2013 - 01:00

Elan urges shareholders to “protect the value of their investment”

Pharmaceutical firm continues to urge shareholders to reject Royalty Pharma offer on grounds it is “grossly inadequate”

Tue Jun 11 2013 - 15:27

Elan drops NY lawsuit and rejects latest Royalty Pharma bid

Bidder calls on shareholders to reject all defensive acquisitions at upcoming EGM

Tue Jun 11 2013 - 01:02

Elan battle intensifies as Royalty Pharma raises offer by 5 per cent

Tysabri manufacturer’s shares rise 5.3 per cent

Sat Jun 08 2013 - 01:00

Elan wins court order to temporarily block take-over attempt

New York judge has issued a temporary restraining order blocking Royalty Pharma from “consummating or closing defendants’ tender offer” for outstanding shares in Elan

Tue Jun 04 2013 - 11:51

Elan says it has ‘Plan B’ if shareholders reject deals

Royalty Pharma last week increased hostile cash bid for Elan

Fri May 31 2013 - 01:00

Cantillon: Hyperactive Elan betting that it can hold shareholders

Drugmaker seems a long way from the measured approach that has typified the tenure of Kelly Martin

Tue May 21 2013 - 12:38

Royalty ups Elan bid by 10%

Irish drugmaker announces two more deals plus plans to raise $800 million

Mon May 20 2013 - 09:05

Markets across globe close fairly flat

Tue May 14 2013 - 11:40

Elan to pay $1bn for Theravance stake

Irish pharmaceutical company agrees to buy 21% of royalty Theravance receives from GSK

Mon May 13 2013 - 07:30

GlaxoSmithKline shares soar after FDA approves lung drug

Sales of Breo Ellipta forecast to reach £703 million by 2020

Thu Apr 18 2013 - 10:11